What's your medical perspective on emerging drugs to complement GLP-1s for muscle building?

With GLP-1s gaining popularity, I'm curious about the potential role of new drugs aimed at muscle building. What are your thoughts on agents like Azelaprag (an apelin receptor agonist exerkine), and monoclonal antibodies such as garetosmab, trevogrumab, and bimagrumab that target myostatin and activin-A? Are optimistic/pessimistic or are you in a wait and see period until the phase 3's commence/finish?